New concepts in the drug therapy of Alzheimer’s disease

By Farlow Martin R   Hake Ann Marie  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 12, 2001-12 ,pp. : 1975-1983

Informa Healthcare

Access to resources Recommend Favorite

Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine

By Suh D-C.  

Drugs & Aging, Vol. 21, Iss. 6, 2004-01 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Vascular Risk Factors and Alzheimer’s Disease Pathogenesis: Are Conventional Pharmacological Approaches Protective For Cognitive Decline Progression?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 2, 2015-03 ,pp. : 257-269

Bentham Science Publishers

Access to resources Recommend Favorite

Dietary Approaches and Supplements in the Prevention of Cognitive Decline and Alzheimer’s Disease

By  

Current Pharmaceutical Design, Vol. 22, Iss. 6, 2016-02 ,pp. : 688-700

Bentham Science Publishers

Access to resources Recommend Favorite

The presenilins as potential drug targets in Alzheimer’s disease

By Cupers P.   Annaert W.G.   Strooper B.D.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 413-422

Informa Healthcare

Access to resources Recommend Favorite